Organization

Department of Preventive Medicine

6 abstracts

Abstract
HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort.
Org: Fudan University Shanghai Cancer Center, China National Biotec Group, West China Hospital, Chengdu Origen Biotechnology, Department of Preventive Medicine,
Abstract
Deep learning-based quantitative assessment of tumor-infiltrating lymphocytes from hematoxylin and eosin-stained slides in triple-negative breast cancer: A prognostic study.
Org: Biomy Inc., Center of Development of Advanced Diagnostics, Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Department of Preventive Medicine, Graduate School of Medicine, Osaka University,
Abstract
Risk of significant functional impairment across cancer diagnosis and care continuum.
Org: Dept. of Physical Therapy and Human Movement Sciences, Northwestern University Feinberg School of Medicine, Dept. of Medical Social Sciences, Northwestern University, Department of Medical Social Sciences,
Abstract
Association of symptom severity, anxiety, and health literacy with portal usage among patients with cancer.
Org: Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Northwestern University, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Department of Medical Social Sciences,
Abstract
Genomic landscapes to characterize mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancers stratified by tumor mutation burden (TMB).
Org: Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, University of Southern California Marshall School of Business, Caris Life Sciences, Irving, TX, Department of Preventive Medicine,
Abstract
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.
Org: Bayer AG, Charité - Universitätsmedizin Berlin, Berlin, Germany, University of Munich, University of Pisa & Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Germany,